IP Library › Assignment 058525/0902
Patent Assignment
Reel/Frame 058525/0902

Assignment of Assignor's Interest

Recorded: 2021-12-16 Pages: 17
Assignors
KUHN, ANDREAS
Executed: 2021-06-20
MURAMATSU, HIROMI
Executed: 2021-06-20
KARIKO, KATALIN
Executed: 2021-06-20
FESSER, STEPHANIE
Executed: 2021-06-20
SAHIN, UGUR
Executed: 2021-06-20
Assignee
BIONTECH RNA PHARMACEUTICALS GMBH
AN DER GOLDGRUBE 12, MAINZ, 55131, GERMANY
Covered Properties (2)
5'-Cap-Trinucleotide- or Higher Oligonucleotide Compounds and Their Use in Stabilizing Rna, Expressing Proteins in Therapy
Application: 16/980,300 →
Publication: US 2021/0363172
5'-Cap Compounds and Their Uses in Stabilizing Rna, Expressing Proteins and in Therapy
Application: 17/371,935 →
Publication: US 2021/0340170
Related Assignments (1)
Other recorded transfers of the patents in this record — the chain of ownership.
Merger Sep 3, 2021
From: BIONTECH RNA PHARMACEUTICALS GMBH
To: BIONTECH SE
Reel/Frame 057418/0943 →